Showing results (51-60 of 95) with videos related to

Sort By:
Pageof 10
International Journal of Nanomedicine|October 6, 2017
Green synthesis of selenium nanoparticles using Acinetobacter sp. SW30: optimization, characterization and its anticancer activity in breast cancer cellsSweety A Wadhwani, Mahadeo Gorain, Pinaki Banerjee, et al.
Cells|June 25, 2020
Desialylation of Sonic-Hedgehog by Neu2 Inhibits Its Association with Patched1 Reducing Stemness-Like Properties in Pancreatic Cancer Sphere-forming CellsShalini Nath, Susmita Mondal, Ramesh Butti, et al.
Nanomedicine (London, England)|February 13, 2013
Modified dipeptide-based nanoparticles: vehicles for targeted tumor drug deliveryJiban J Panda, Ankur Kaul, Santosh Kumar, et al.
The Journal of Organic Chemistry|October 2, 2013
One-pot fluorescent labeling protocol for complex hydroxylated bioactive natural productsSaikat Haldar, Santosh Kumar, Swati P Kolet, et al.
Oncology Letters|November 22, 2013
Association of osteopontin and cyclooxygenase-2 expression with breast cancer subtypes and their use as potential biomarkersDhanashri Thorat, Asutosh Sahu, Reeti Behera, et al.
Nanoscale|May 7, 2020
RGD functionalized chitosan nanoparticle mediated targeted delivery of raloxifene selectively suppresses angiogenesis and tumor growth in breast cancerAmit S Yadav, N Naga Venkata Radharani, Mahadeo Gorain, et al.
Biomaterials Science|February 9, 2021
Continuous flow fabrication of Fmoc-cysteine based nanobowl infused core-shell like microstructures for pH switchable on-demand anti-cancer drug deliverySonika Chibh, Vibhav Katoch, Avneet Kour, et al.
Nanotheranostics|April 17, 2023
Hybrid Inorganic Complexes as Cancer Therapeutic Agents: In-vitro ValidationMurlidhar A Betallu, Shaileshkumar R Bhalara, Kailash B Sapnar, et al.
Molecular Cancer|May 7, 2024
Modulation of the tumor microenvironment and mechanism of immunotherapy-based drug resistance in breast cancerMoumita Kundu, Ramesh Butti, Venketesh K Panda, et al.
ACS Biomaterials Science & Engineering|September 13, 2024
Engineered PLGA Core-Lipid Shell Hybrid Nanocarriers Improve the Efficacy and Safety of Irinotecan to Combat Colon CancerPrabhanjan S Giram, Ramakrishna Nimma, Anuradha Bulbule, et al.
Pageof 10